We are live on
!
Find out more
CCP
Corbin Capital Partners Portfolio holdings
AUM
$61.3M
1-Year Est. Return
53.03%
This Fund
S&P 500
This Quarter
Est. Return
+12.38%
1 Year Est. Return
+53.03%
3 Year Est. Return
+87.66%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$59.1M
AUM Growth
+$35.2M
(+147%)
Cap. Flow
+$31.6M
Cap. Flow
% of AUM
53.38%
Top 10 Holdings %
Top 10 Hldgs %
91.57%
Holding
50
New
6
Increased
1
Reduced
2
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMBT
CMB.TECH NV
CMBT
|
+$19.6M |
| 2 |
TDCX
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
|
+$9.87M |
| 3 |
Core Scientific
CORZ
|
+$3.15M |
| 4 |
Arbutus Biopharma
ABUS
|
+$2.21M |
| 5 |
Roivant Sciences
ROIV
|
+$1.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$5.35M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.09M |
| 3 |
SLAMW
Slam Corp. warrant
SLAMW
|
+$214K |
| 4 |
Tevogen Bio Warrant
TVGNW
|
+$51.4K |
| 5 |
PRST
Presto Technologies, Inc. Common Stock
PRST
|
+$40.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 31.53% |
| 2 | Technology | 23.33% |
| 3 | Healthcare | 13.78% |
| 4 | Real Estate | 5.7% |
| 5 | Materials | 3.6% |
Similar funds
AFA
MCC
AIM
IP
JCP
GGV
APWM
SGL
Corbin Capital Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Corbin Capital Partners held 50 positions worth $59.1M, up 147% from $23.9M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Corbin Capital Partners deployed $31.6M of net new capital in Q1 2024, opening 6 new positions and adding to 1 existing holding. Its largest new stake was CMB.TECH NV: 1,126,164 shares worth $18.6M.
By sector, the portfolio is most concentrated in Energy at 32% of assets, followed by Technology and Healthcare.
On the sell side, the largest reduction was Tevogen Bio Warrant, an estimated $51.4K trimmed.
- Corbin Capital Partners's largest Q1 2024 buy was CMB.TECH NV: 1,126,164 shares worth $18.6M.
- Corbin Capital Partners added most to Odyssey Marine Exploration in Q1 2024, an estimated $941K increase.
- Corbin Capital Partners's biggest Q1 2024 reduction was Tevogen Bio Warrant, cutting an estimated $51.4K.
- Corbin Capital Partners fully exited Invesco S&P 500 Equal Weight ETF in Q1 2024, selling an estimated $5.35M.
- Corbin Capital Partners's ten largest holdings make up 92% of its $59.1M portfolio in Q1 2024.
- Corbin Capital Partners opened 6 new positions and closed 7 in Q1 2024.
- Corbin Capital Partners's portfolio value rose 147% quarter-over-quarter to $59.1M.
Based on Corbin Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.